Iterum Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$38,371,000 over the previous period. Total operating expenses were $47,468,000.
Profit Margin
| 2016 | 0 | -13.46M | |
|---|---|---|---|
| 2017 | 508K | -29.40M | -5788.58% |
| 2018 | 869K | -77.05M | -8867.2% |
| 2019 | 37K | -103.13M | -278729.73% |
| 2020 | 0 | -52.00M | |
| 2021 | 0 | -91.56M | |
| 2022 | 0 | -44.43M | |
| 2023 | 0 | -38.37M |
ITRM Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 37K | 869K | 508K | 0 |
Cost of revenue | 1.75M | 1.8M | 2.10M | 161K | 0 | 0 | 0 | 0 |
Gross profit | -1.75M | -1.8M | -2.10M | -161K | 37K | 869K | 508K | 0 |
Operating exp. | ||||||||
Research and development | 39.99M | 17.61M | 10.71M | 21.07M | 90.77M | 68.64M | 25.49M | 10.10M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 47.46M | 30.38M | 24.53M | 32.12M | 102.05M | 77.42M | 29.96M | 13.35M |
Operating income | -47.46M | -30.38M | -24.53M | -32.12M | -102.02M | -76.55M | -29.45M | -13.35M |
Other income (expenses), net | 9.71M | -13.75M | -66.32M | -19.13M | -665K | 401K | 493K | 8K |
Income before tax | -37.75M | -44.13M | -90.85M | -51.26M | -102.68M | -76.58M | -28.96M | -13.35M |
Income tax expense | 613K | 301K | 705K | 743K | 444K | 472K | 444K | 113K |
Net income | -38.37M | -44.43M | -91.56M | -52.00M | -103.13M | -77.05M | -29.40M | -13.46M |
Earnings per share | ||||||||
Basic EPS | -2.96 | -3.63 | -0.56 | -2.17 | -7.1 | -132.34 | -58.08 | -26.59 |
Diluted EPS | -2.96 | -3.63 | -0.56 | -2.17 | -7.1 | -132.34 | -58.08 | -26.59 |
| Data source | Data source | Data source | Data source | Data source | Data source |